Presenter(s): John F. Kelly, PhD, ABPP; Elizabeth R. Spallin Associate Professor of Psychiatry in Addiction Medicine, Harvard Medical School
Webinar description: Twelve-step based treatments and related community mutual-aid organizations, such as AA and NA, to which patients are referred, have come under scrutiny and criticism in the press and popular media in recent years being branded as “outdated” and “not evidence-based”. Polemical debates have raged, fueled by confusion about the state of the science on these treatment and recovery support approaches or misrepresentations of existing research. This webinar will present results from comprehensive, gold-standard, reviews of the scientific clinical literature, investigate the health care cost savings obtainable by implementing mutual-aid facilitation approaches in clinical settings, and discuss the implications for clinical practice, addiction treatment and public health broadly.
- Describe the state of the evidence on the efficacy of mutual-aid for enhancing clinical outcomes for opioid and other substance use disorders.
- Detail the magnitude of the potential health care cost savings that can be derived from prescribing and facilitating mutual-aid participation in treatment settings.
- List three major mechanisms through which mutual-aid organizations confer therapeutic benefit.
The American Psychiatric Association (APA) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
American Psychiatric Association (APA) designates this live activity for a maximum of 1 (one) AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.